Your browser doesn't support javascript.
loading
Time to treatment response of a magnesium- and sulphate-rich natural mineral water in functional constipation.
Dupont, Christophe; Constant, Florence; Imbert, Aurélie; Hébert, Guillaume; Zourabichvili, Othar; Kapel, Nathalie.
Affiliation
  • Dupont C; Service d'Explorations Fonctionnelles Digestives Pédiatriques, AP-HP, Hôpital Necker Enfant Malade, Université Paris Descartes, Paris, France. Electronic address: Christophe.dupont@nck.aphp.fr.
  • Constant F; Nestlé Waters M.T., Issy-les-Moulineaux, France.
  • Imbert A; Nestlé Waters M.T., Issy-les-Moulineaux, France.
  • Hébert G; SC Partners, Paris, France.
  • Zourabichvili O; Quanta Medical, Rueil-Malmaison, France.
  • Kapel N; Laboratoire de Coprologie Fonctionnelle, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, APHP, Paris, France.
Nutrition ; 65: 167-172, 2019 09.
Article in En | MEDLINE | ID: mdl-31170680
OBJECTIVES: First-line recommendations for the management of functional constipation include nutritional-hygienic measures. We previously showed that a natural mineral water rich in sulphates and magnesium (Hépar) is efficient in the treatment of functional constipation. The aim of this study was to consolidate those first results and determine a precise time to respond to Hépar. METHODS: This multicenter, randomized, double-blind, controlled study of the effect of Hépar on stool consistency and frequency in functional constipation included 226 outpatients. After washout, patients used 1.5 L of water daily, including 1 L of Hépar or of low-mineral water, during 14 d. In addition to a daily reporting of stool consistency by the patient, an expert investigator blindly analyzed stool consistency (Bristol stool scale) based on photographs taken by the patient. RESULTS: The primary endpoint was met. Treatment response was more frequent in the Hépar arm than in the control group at day 14 (50% versus 29%, respectively; P = 0.001). Mean time to treatment response was shorter in the Hépar group (6.4 d) than in the control arm (7.3 d; P = 0.013). Concomitant stool scoring was available for 60% of the patients. Scores given to 79% of the stools were similar between the patient and the expert (differences ≤1). Safety analyses showed excellent results. CONCLUSION: This study confirms the efficacy and safety of Hépar in the treatment of functional constipation and shows that it is associated with a response within 7 d. Hépar could be a safe response to the current absence of first-line medication in the treatment of functional constipation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfates / Constipation / Magnesium / Mineral Waters / Minerals Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Nutrition Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfates / Constipation / Magnesium / Mineral Waters / Minerals Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Nutrition Year: 2019 Document type: Article